Sign In
Buy NVZMY
$65.04
-0.650 (-0.99%)
At Close: Jul 31, 2026
Novozymes is set to merge with Chr. Hansen as part of a historic deal
06:14am, Monday, 12'th Dec 2022
Ester Baiget, CEO of Novozymes, discusses the planned merger of bioscience firms Novozymes and Chr. Hansen.
Novozymes and Chr. Hansen agree deal to merge
03:08am, Monday, 12'th Dec 2022
By Dominic Chopping
COP27: The private sector needs to step up, says Novozymes CEO
05:49am, Friday, 11'th Nov 2022
Ester Baiget, Novozymes CEO, says there needs to be more dialogue.
Novozymes A/S (NVZMF) Q3 2022 Earnings Call Transcript
10:27pm, Friday, 04'th Nov 2022
Novozymes A/S (OTCPK:NVZMF) Q3 2022 Earnings Conference Call November 3, 2022 4:00 AM ET Company Participants Tobias Cornelius Bjorklund - Head-Investor Relations Ester Baiget - Chief Executive Office
Novozymes A/S (NVZMF) CEO Ester Baiget on Q2 2022 Results - Earnings Call Transcript
03:17pm, Thursday, 11'th Aug 2022
Novozymes A/S (OTCPK:NVZMF) Q2 2022 Earnings Conference Call August 11, 2022 3:00 AM ET Company Participants Tobias Bjorklund - Head of IR Ester Baiget - President and CEO Lars Green - Executive VP an
AXTA vs. NVZMY: Which Stock Is the Better Value Option?
01:10pm, Thursday, 14'th Jul 2022
AXTA vs. NVZMY: Which Stock Is the Better Value Option?
ESI vs. NVZMY: Which Stock Should Value Investors Buy Now?
01:13pm, Monday, 20'th Jun 2022
ESI vs. NVZMY: Which Stock Is the Better Value Option?
ICL vs. NVZMY: Which Stock Is the Better Value Option?
12:48pm, Tuesday, 31'st May 2022
ICL vs. NVZMY: Which Stock Is the Better Value Option?
Novozymes CEO: We must stop subsidizing the past
03:31am, Wednesday, 25'th May 2022
Novozymes CEO Ester Baiget discusses Europe's energy transition and her views on energy subsidies and carbon taxes.
Novozymes A/S (NVZMF) CEO Ester Baiget on Q1 2022 Results - Earnings Call Transcript
02:35pm, Wednesday, 27'th Apr 2022
Novozymes A/S (OTCPK:NVZMF) Q1 2022 Results Conference Call April 27, 2022 3:00 AM ET Company Participants Tobias Bjorklund - Head, IR Ester Baiget - CEO Lars Green - CFO Tina Fanoe - EVP, Agriculture
Novozymes A/S (NVZMF) CEO Ester Baiget on Q4 2021 Results - Earnings Call Transcript
03:15pm, Tuesday, 01'st Feb 2022
Novozymes A/S (NVZMF) CEO Ester Baiget on Q4 2021 Results - Earnings Call Transcript
Novozymes CEO: Very pleased to finish year on 6% growth
04:38am, Tuesday, 01'st Feb 2022
Novozymes CEO Ester Baiget talks through the company's fourth-quarter earnings and what investors can expect across 2022.
Novozymes reports Q4 operating profit below estimates
02:11am, Tuesday, 01'st Feb 2022
Enzymes maker Novozymes on Tuesday reported fourth quarter operating profit slightly below expectations but said it expected sales to grow organically by between 3-7% in the next financial year.
CE vs. NVZMY: Which Stock Should Value Investors Buy Now?
01:03pm, Tuesday, 28'th Dec 2021
CE vs. NVZMY: Which Stock Is the Better Value Option?
21st.BIO Raises 86M In Funding
09:58am, Thursday, 23'rd Dec 2021 FinSMEs
21st.BIO, a Copenhagen, Denmark-based new bioindustrial scale-up company building on technology base from Novozymes, raised 86m in funding. Novo Holdings made the investment. In conjunction with the funding, Søren Møller, Managing Partner of Novo Seeds, Novo Holdings, will join the Board of Directors. The investment will enable the company to expand its capacity further. Established in [] The post 21st.BIO Raises 86M In Funding appeared first on FinSMEs .
